Exploring pharmacological mechanism of Magnoliae Officinalis Cortex based on systems pharmacology / 中草药

ABSTRACT

Objective: To explore the pharmacological mechanism of traditional Chinese medicine (TCM) Magnoliae Officinalis Cortex by systems pharmacology (SP). Methods: A database of magnolia components was established by using the database of TCM ingredients and a large number of literature search. After that, ADME was used to screen the active compounds of magnolia, and these ingredients and an in silico software were used to identify targets. Finally, the pharmacological mechanism of magnolia was analyzed by SP methods network analysis and pathway analysis. Results: The most comprehensive database of magnolia ingredients to date have been established, containing a total of 144 magnolia compounds. After screening, we obtained seven magnolia active compounds which meet the conditions and identified 54 interacting targets. The network analysis showed that these targets were mainly related to intestinal motility, inflammation, diabetes and thrombus. Through pathway analysis, we found that a total of 152 biological pathways were involved in the targets of magnolia, and these pathways were involved in cancer-related mechanisms in addition to the above diseases. Conclusion: This study not only uses SP to reveal the pharmacological mechanisms of magnolia on intestinal motility, inflammation, diabetes, thrombus and cancer, but also reflects the typical “multi-component, multi-target, multi-channel” TCM characteristics of magnolia and provides a new SP technology to explore the pharmacological mechanism of TCM.